PMC studies the clinical and economic value of personalized health care approaches across a broad range of disease states.
![]() “Cost-Effectiveness of Exome and Genome Sequencing for Children With Rare and Undiagnosed Conditions,” Genetics in Medicine |
![]() "Clinical and Economic Value of Genetic Sequencing for Personalized Therapy in Non-small-cell Lung Cancer," Clinical Lung Cancer |
![]() Personalized Medicine and Value Assessment Frameworks: Context, Considerations, and Next Steps |
Daryl Pritchard, Ph.D., Senior Vice President, Science Policy
Lindsay Stephens, Senior Operations Manager and Secretary to the Board